It is reported that AMMECR1 is associated with growth, bone, and heart alterations; CLDN11 is an epigenetic biomarker for malignancy, and THOC2 mutations are related to X-linked intellectual disability [50–52]. This evidence concerns the gene AMMECR1 and X-linked intellectual disability.